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Danish version of ‘The COPD self-efficacy scale’:
translation and psychometric properties
The aim of the study was to translate ‘The COPD self-
efficacy scale’ (CSES) into Danish and to evaluate the
psychometric properties of the Danish version (CSES-DK).
CSES enables assessment of self-efficacy in individuals
with chronic obstructive pulmonary disease (COPD). The
scale consists of 34 items, describing situations which may
cause dyspnoea in patients with COPD. The CSES was
translated into Danish using a standard forward–backward
translation procedure. To estimate the reliability, mea-
surements of internal consistency and repeatability were
applied. The validity of the Danish version was evaluated
by examining the associations between the CSES-DK score
and socio-demographic variables (age, gender, education,
disease severity and self-rated health). Factor analysis was
conducted to compare the internal structure of the Danish
version and the American source version. The study
included 151 patients with COPD, recruited from three
outpatient clinics. Estimates of reliability were in accor-
dance with the original version of CSES (Cronbach’s
a = 0.97, test-retest r = 0.82, p < 0.001). Significant cor-
relations were obtained between the CSES-DK total score
and vocational training and education (r = 0.27, p =
0.001), disease severity (r = )0.27, p = 0.001) and self-
rated health (r = )0.41, p < 0.001), indicating construct
validity. Five factors were extracted from both versions of
CSES. However, in the CSES-DK, only one factor concerns
emotions, whereas two factors describing emotions were
obtained for the original scale. Furthermore, important
discrepancies exist with respect to the direction of the
scoring of CSES. In some studies, a high score indicates
high self-efficacy, whereas it indicates low self-efficacy in
other studies, which complicates the comparison of stud-
ies. The Danish version of CSES showed acceptable mea-
surements of reliability and validity. Potential limitations
of the scale were identified, and discrepancies exist
between the factor structure of the original and Danish
version. Consequently, more studies of the factor structure
should be conducted on both the original CSES and the
translated versions of the instrument.
Keywords: chronic obstructive pulmonary disease, self-
efficacy, COPD self-efficacy scale, translation, psychometric
properties, factor analysis.
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Introduction
Dyspnoea is the most significant symptom in chronic
obstructive pulmonary disease (COPD) and increases as the
disease progresses (1). Dyspnoea has implications for the
patients’ daily activities and may lead to physical impair-
ment and confinement to the home (2). However, these
restrictions may not only be due to physical disabilities
because research has shown associations between dysp-
noea, functional performance and self-efficacy in patients
with COPD (3). Self-efficacy refers to the patient’s beliefs in
his capabilities to execute the courses of action required to
attain important goals. Control is a key concept in self-
efficacy theory and does not only concern control of
behaviour, but also self-regulation of thought processes,
motivation and physical condition. According to the theory,
the patient can interpret bodily signals such as dyspnoea
and physical deterioration as a loss in physical capacity,
which can influence the COPD patient’s self-efficacy neg-
atively (4). Hence, the patient’s self-efficacy beliefs may
influence the activities and behaviour of the patient (5).
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Chronic obstructive pulmonary disease patients’ confi-
dence in their ability to control their breathing difficulties
has been identified as a predictor for preference of home
care treatment of exacerbation (6). Furthermore, self-
efficacy is associated with anxiety, quality of life (7),
depression and exercise tolerance in patients with COPD
(8). Hence, self-efficacy is an important clinical outcome
when researching within the field of treatment and care
for patients with COPD.
According to Bandura (4), self-efficacy should not be
seen as an omnibus trait but as a differentiated set of self-
beliefs linked to distinct realms of functioning, which
suggests that a dimension-specific scale should be used
when assessing self-efficacy in patients with COPD (9).
‘The COPD self-efficacy scale’ (CSES), developed by Wigal
et al. (5), aims at assessing self-efficacy in individuals af-
flicted by COPD. The scale consists of 34 items describing
situations, which may cause dyspnoea in patients with
COPD. The respondents are asked to rate, on a five point
scale (10), their confidence in their ability to manage or
avoid breathing difficulties in a variety of situations (5). An
overall self-efficacy score can be derived calculating the
sum of the individual item scores and, if preferred, this
sum may be divided by the number of items to derive an
average score per item. For both the total score and the
average item score, low scores indicate low self-efficacy
(8). Based on a principal component analysis, five factors
have been extracted from the American version of CSES:
negative effect, intense emotional arousal, physical exer-
tion, weather/environment and behavioural risk factors
(5). If this factor structure can be demonstrated to be
robust, it may form the basis for a more differentiated
scoring of the instrument.
According to Bandura (4), people rely partly on somatic
information conveyed by physiological and emotional
states, especially in domains that involve health func-
tioning. Thus, the CSES score may be associated with
health functioning measurements such as self-rated health
and disease severity. In social cognitive theory, internal
factors, behaviour and the external environment influence
one another bidirectionally. Furthermore, Bandura (4)
states that personal agency operates within a broad net-
work of sociostructural influences. Based on these
assumptions, an association between self-efficacy and
educational level may be found.
The CSES was originally validated on 102 outpatients
(54 men, 48 women, mean age 66.8 years, SD 8.6) diag-
nosed with chronic bronchitis, emphysema or both. CSES
displays satisfactory psychometric properties with Cron-
bach’s a = 0.95 and test-retest reliability, r = 0.77 (5). To
apply CSES into a Danish context, a Danish version is
needed, and therefore, the aim of the study was to trans-
late ‘The COPD self-efficacy scale’ into Danish and to
evaluate the psychometric properties, reliability and
validity of the Danish version (CSES-DK).
Materials and methods
The study consisted of three parts; translation of CSES into
Danish, followed by a pilot test and subsequently an
evaluation of the psychometric properties of the Danish
version of CSES.
Translation procedure
Permission to translate and use CSES was obtained from
the corresponding author of the paper presenting the
source version of CSES (5).
The translation of CSES was performed using a standard
forward–backward translation procedure (11). Three
independent translations were carried out (by the authors
CE, SRH, ELM) and merged to create a common version.
This version was back-translated into English by a native
English-speaking psychologist. The back-translation was
compared to the source version by a committee (12, 13)
consisting of four health professionals (CE, SRH, BØ, KP)
familiar with patients with COPD. The committee found
minor discrepancies between the source version and the
back-translation which, in most cases, reflected the richer
vocabulary in the English language.
The final version of CSES-DK was pilot tested in five
outpatients with COPD. As a consequence of the pilot test,
the introduction to the questionnaire was simplified be-
cause the patients had difficulties understanding the
instructions.
Participants
The participants in the study were recruited from three
outpatient clinics in the greater Copenhagen area. To
participate, the patients had to have been diagnosed with
COPD (FEV1 < 80%, FEV1/FVC < 0.7) (14) before the
current visit to the outpatient clinic. All four stages of
COPD, as classified by GOLD (15), were included in the
study. Exclusion criteria were inability to read and
understand Danish and cognitive impairments that might
cause difficulties understanding the information and
instructions for the study. This was evaluated by the
investigator and the health professionals at the outpatient
clinics.
There is no consensus regarding the necessary sample size
in validation studies (16), but this study aimed at including
a minimum of 100 patients (9). Age, gender and disease
severity were registered for all potential respondents to
identify possible differences between the patients partici-
pating in the study and the patients that declined (17).
The study was approved by the Danish Data Protection
Agency. Approval was not required from the Danish Sci-
entific Ethical Committee because the study only involves
questionnaire data. Before entering the study, eligible
patients received oral and written information about the
 2012 The Authors
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study. Informed consent was obtained after the partici-
pants had been informed about their right to withdraw
from the study, confidentiality and the protection of ano-
nymity.
Design of the validation study
A cross-sectional sample of patients with COPD was
recruited from the three outpatient clinics over a 10-
month period in 2009. All participants received both oral
and written instructions and could answer the question-
naire either during their visit to the clinic or at home,
provided with a stamped and addressed envelope. Partici-
pants who completed the questionnaire were mailed a
second copy of the questionnaire with a stamped envelope
within 2 weeks after returning the first questionnaire. If an
item was omitted, respondents were asked to note the
reason for this, to identify the reasons for omissions (10).
For validation purposes, the respondents were asked to
complete a supplementary questionnaire, providing infor-
mation about gender, age, educational level, number of
years with COPD and self-rated health. Information on
educational level was obtained with a question on
schooling (five levels) and a question on vocational
training and education (five levels).
Information about the respondents’ self-rated health
was obtained using a single question on self-reported glo-
bal health. The respondents were asked to rate their health
in general as: very good = 1, good = 2, fair = 3, poor = 4,
very poor = 5 (18). Furthermore, the respondents’ FEV1
and disease severity were registered, using the GOLD
guidelines (15).
Analysis
The distribution of the CSES-DK total score was evaluated
by calculating skewness and kurtosis, and by the one
sample Kolmogorov–Smirnov test. These analyses sug-
gested that the scores were approximately normal distrib-
uted and, consequently, means and SDs will be presented.
To optimise the statistical power, all analyses were
conducted on a dataset with imputed item scores (9). The
imputed scores were derived by assigning the mean of the
respondent’s completed items to the missing items (10).
To estimate the reliability of the CSES-DK, measure-
ments of internal consistency (Cronbach’s a coefficient)
and repeatability (test-retest measured by Pearson’s r)
were applied. The test-retest correlation was based on the
scores of the respondents who had completed both copies
of the questionnaire. The validity of the Danish version of
CSES was evaluated by examining the Pearson correlations
between disease- and socio-demographic variables and the
test score on CSES-DK (19).
The factor structure of the original version of CSES was
evaluated by principal component factor analysis with
Varimax rotation (5). To compare the source version to the
Danish version of the questionnaire, this analysis was also
conducted on the scores from the first administration of
the CSES-DK. However, because it is likely that the
underlying factors may be correlated, an oblique Promax
rotation will be presented instead of the Varimax rotation
(9). Furthermore, the observed factor structure was used to
derive subscales of the Danish version of CSES. Coefficient
alpha was used to evaluate the reliability of these scales,
and Pearson correlations were used to evaluate associa-
tions among the subscales (19).
The data analyses were carried out using SPSS 17.0 for
Windows (SPSS Inc., Chicago, IL, USA). A p-value < 0.05
was considered statistically significant.
Results
Participants
One hundred and eighty-nine patients met the inclusion
criteria of whom 163 patients agreed to participate. A total
of 151 patients returned the first administration of the
questionnaire, resulting in a response rate of 92.6%. The
participants had a mean age of 67.56 years (SD 9.75),
ranging from 36 to 87 years. Number of years with COPD
ranged from 0 to 32 (mean 5.94 years, SD 6.19).
One hundred and twenty-seven respondents received
the second administration of the questionnaire; hence, 24
respondents were not invited to participate in the retest.
This group consisted of four patients who did not wish to
participate in the retest, and 20 patients who were
recruited while participating in a COPD rehabilitation
programme and therefore not eligible for the retest. One
hundred and four patients returned the second question-
naire, resulting in a response rate of 81.9%. However, two
patients were excluded from the analyses because of late
return of the retest questionnaire (>100 days).
Table 1 presents characteristics for respondents and
nonrespondents. The analyses showed no significant dif-
ferences between the respondents and nonrespondents at
the first or second administration.
Scale properties
The calculation of skewness and kurtosis (skewness =
)0.04 and kurtosis = )0.62) and the one sample Kol-
mogorov–Smirnov test (p = 0.86) suggested that the dis-
tribution of the total score was approximately normal.
A total of 103 (68%) respondents completed the first
administration of CSES-DK without any missing items.
Seventeen percent of the returned questionnaires had one
missing item. Furthermore, two missing items occurred in
5% of the questionnaires and 6% had three missing items.
The highest omission rates were on item 6, ‘when I try to
deny that I have respiratory difficulties’, item 11, ‘when I
 2012 The Authors
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feel sexually inadequate or impotent’, and item 21, ‘when
I drink alcoholic beverages’ (9.3, 13.9 and 8.6%, respec-
tively). Table 2 presents the completion rate, mean score
and standard deviation for each item.
The mean total score in the first administration
(n = 151) was 111.62 (SD 29.02), with scores ranging from
38 to 170. The second administration (n = 102) displayed a
total mean score of 109.25 (SD 32.41), ranging from 34 to
170. A paired samples t-test showed a statistically signifi-
cant difference between the total score in the first and
second administration of the questionnaire (t = 2.50,
df = 101, p = 0.01).
Reliability
The Cronbach’s a coefficient was 0.97 for the first
administration of the questionnaire. Retest analyses were
performed on 102 respondents. As illustrated in Table 1,
the respondents and the nonrespondents in the retest did
not differ significantly with regard to gender, age or disease
severity. The respondents returned the retest question-
naire within 11–47 days (mean 24.64, SD 7.41) after the
first administration. The Pearson correlation between the
first and second administration of CSES-DK was r = 0.82,
p < 0.001. Thus, the estimates of reliability are in accor-
dance with the original version of CSES (5).
Validity
The item-total correlations ranged from 0.40 to 0.79 (see
Table 2), indicating high internal consistency. Table 3
displays the correlations between the CSES-DK total score
and the socio-demographic variables. Age, years with
COPD and schooling were not significantly correlated with
the CSES-DK score. Correlations between the CSES-DK
score and a number of variables were moderate, but highly
significant: vocational training and education (r = 0.27,
p = 0.001), disease severity (r = )0.27, p = 0.001) and self-
rated health (r = )0.41, p < 0.001).
Factor structure of the CSES-DK
The factor analysis was based on data from the first
administration of CSES-DK (n = 151). Using the eigen-
values >1 criterion, five factors were extracted (9),
explaining 69.7% of the total variance. The Promax
rotated factors are presented in Table 4.
The first factor extracted accounted for 14% of the
variance. The 16 items loading on this factor are associated
with emotions. The second factor, which explained 10% of
the variance, included eight items which are primarily
related to physical strain. Factor 3 accounted for 9% of the
variance and consisted of four items associated with
weather/environment. The fourth factor consisted of two
items related to diet/alcohol and accounted for 5.5% of the
variance, whereas factor 5 accounted for 7% of the vari-
ance and consisted of four items. These items are con-
cerned with physical and emotional exhaustion. Item 18,
‘when I laugh a lot’, had high loadings on four of the five
factors (0.53–0.58) and thus, the factorial status of this
item remains ambiguous.
Table 5 presents the Pearson correlations between the
extracted factors in the Danish version of CSES. The cor-
relations are predominantly high, except the correlation
between factor 2 and factor 4 (r = 0.22). The high corre-
lations, especially between the factor scores and the CSES-
DK score, indicate substantial overlap between the results
of each factor and the CSES-DK score.
Table 1 Respondents and nonrespondents in the first and second administration
First administration Second administration
Respondents
n = 151
Nonrespondents
n = 38 p
Respondents
n = 102
Nonrespondents
n = 23 p
Gender (%)
Male 61 (40.4) 11 (28.9) 0.19a 37 (36.3) 9 (39.1) 0.80a
Female 90 (59.6) 27 (71.1) 65 (63.7) 14 (60.9)
Age (years), mean (SD) 67.56 (9.75) 67.37 (12.36) 0.93b 67.08 (9.41) 66.93 (12.15) 0.65b
COPD stage (%)
Mild 3.3 2.9 0.55a,c 2.0 4.3 0.28a,c
Moderate 33.3 34.2 38.2 34.8
Severe 42.7 48.6 38.2 52.2
Very severe 20.7 14.3 21.6 8.7
COPD, chronic obstructive pulmonary disease.
aChi-square.
bIndependent t-test.
cRecoded into three categories (mild–moderate, severe and very severe COPD).
 2012 The Authors
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Table 2 Completion rate, mean score, SD and item-total correlation for each item in the COPD self-efficacy scale (CSES)-DK
Item
number Itema N
Mean
score SD
Item-total
correlation
1. When I become too tired 150 3.70 1.09 0.68
2. When there is humidity in the air 151 3.23 1.28 0.63
3. When I go into cold weather from a warm place 151 3.34 1.10 0.64
4. When I experience emotional stress or become upset 151 3.31 1.18 0.65
5. When I go up stairs too fast 150 2.93 1.40 0.59
6. When I try to deny that I have respiratory difficulties 137 3.26 1.24 0.72
7. When I am around cigarette smoke 150 3.49 1.22 0.62
8. When I become angry 150 3.43 1.18 0.72
9. When I exercise or physically exert myself 148 2.95 1.39 0.60
10. When I experience too much excitement 150 3.28 1.23 0.78
11. When I feel sexually inadequate or impotent 130 3.20 1.36 0.75
12. When I am frustrated 149 3.48 1.18 0.79
13. When I lift heavy objects 148 2.87 1.42 0.64
14. When I begin to feel that someone is out to get me 147 3.32 1.31 0.75
15. When I yell or scream 141 3.36 1.25 0.76
16. When I am lying in bed 150 3.94 1.18 0.40
17. During very hot or very cold weather 149 3.21 1.21 0.58
18. When I laugh a lot 149 3.60 1.12 0.62
19. When I do not follow a proper diet 150 3.67 1.21 0.48
20. When I feel helpless 151 3.30 1.24 0.74
21. When I drink alcoholic beverages 138 3.66 1.24 0.49
22. When I get an infection 150 2.80 1.29 0.61
23. When I feel detached from everyone and
everything
145 3.38 1.26 0.69
24. When I experience anxiety 150 3.09 1.31 0.71
25. When I am around pollution 150 3.04 1.27 0.65
26. When I overeat 149 3.42 1.29 0.63
27. When I feel down or depressed 150 3.44 1.26 0.75
28. When I breathe improperly 151 2.90 1.27 0.72
29. When I exercise in a room that is poorly ventilated 144 2.82 1.31 0.59
30. When I am afraid 149 3.19 1.28 0.72
31. When I experience the loss of a valued object or a
loved one
149 3.09 1.30 0.67
32. When there are problems in the home 149 3.54 1.19 0.70
33. When I feel incompetent 147 3.59 1.16 0.69
34. When I hurry or rush around 149 2.85 1.44 0.60
COPD, chronic obstructive pulmonary disease.
aThe questionnaire is introduced by the following phrase; ‘Determine how confident you are that you could manage breathing difficulty or avoid
breathing difficulty in that situation’ (5).
Table 3 Correlations between the COPD
self-efficacy scale (CSES)-DK total score and
disease- and socio-demographic variables
Pearson correlations
(95% CI) p
Gender 0.10 ()0.06, 0.25) 0.23
Age )0.02 ()0.18, 0.14) 0.77
Years with COPD )0.06 ()0.22, 0.11) 0.48
Disease severity (GOLD stage) )0.27* ()0.41, )0.11) 0.001
Self-rated health )0.41* ()0.54, )0.27) <0.001
Schooling 0.13 ()0.03, 0.29) 0.11
Vocational training and education 0.27* (0.12, 0.42) 0.001
CI, confidence interval; COPD, chronic obstructive pulmonary disease.
*Correlation is significant at the 0.01 level (two-tailed).
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Table 4 The factor structure of the COPD self-efficacy scale (CSES)-DK (Promax rotation)
Item number Item Loading
Factor 1: Emotions
Cronbach’s a coefficient = 0.96, 14% of the variance
4. When I experience emotional stress or become upset 0.77
8. When I become angry 0.78
10. When I experience too much excitement 0.83
11. When I feel sexually inadequate or impotent 0.72
12. When I am frustrated 0.84
14. When I begin to feel that someone is out to get me 0.72
15. When I yell or scream 0.74
20. When I feel helpless 0.81
23. When I feel detached from everyone and everything 0.79
24. When I experience anxiety 0.81
26. When I overeat 0.64
27. When I feel down or depressed 0.86
30. When I am afraid 0.83
31. When I experience the loss of a valued object or a loved one 0.78
32. When there are problems in the home 0.80
33. When I feel incompetent 0.78
Factor 2: Physical strains
Cronbach’s a coefficient = 0.93, 10% of the variance
5. When I go up stairs too fast 0.82
9. When I exercise or physically exert myself 0.85
13. When I lift heavy objects 0.78
22. When I get an infection 0.74
25. When I am around pollution 0.82
28. When I breathe improperly 0.84
29. When I exercise in a room that is poorly ventilated 0.84
34. When I hurry or rush around 0.83
Factor 3: Weather/environment
Cronbach’s a coefficient = 0.85, 9% of the variance
2. When there is humidity in the air 0.83
3. When I go into cold weather from a warm place 0.76
7. When I am around cigarette smoke 0.71
17. During very hot or very cold weather 0.77
Factor 4: Diet/alcohol
Cronbach’s a coefficient = 0.71, 5.5% of the variance
19. When I do not follow a proper diet 0.77
21. When I drink alcoholic beverages 0.73
Factor 5: Physical and emotional exhaustion
Cronbach’s a coefficient = 0.79, 7% of the variance
1. When I become too tired 0.73
6. When I try to deny that I have respiratory difficulties 0.69
16. When I am lying in bed 0.81
18. When I laugh a lot 0.61
COPD, chronic obstructive pulmonary disease.
 2012 The Authors
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Discussion
The present study has generated a Danish version of ‘The
COPD self-efficacy scale’. The reliability estimates for the
Danish version of CSES were similar to the estimates
obtained for the original version of the scale (5).
The high item-total correlations and the correlations
between the derived factors suggest that CSES-DK scores
primarily reflect a single construct. Furthermore, the
results of the analyses suggest that the underlying con-
struct is associated with the respondents’ perception of
their own health and the disease severity. The association
between self-rated health, disease severity and CSES-DK
total score is in line with Bandura’s self-efficacy theory,
describing how bodily signals and symptoms can influ-
ence the patients’ self-efficacy (4). Thus, these results
may be interpreted as an indication of construct validity
(19).
The results showed a small and insignificant correlation
between the CSES-DK score and schooling, and a moder-
ate and significant correlation between the CSES-DK score
and vocational training and education. The significant
correlation is in contrast to the Norwegian validation study
of CSES, which did not find a significant correlation
between CSES and education (20), but the Norwegian
study did not discriminate between schooling and voca-
tional training and education.
Other studies have reported findings similar to the
results of the present study. The Pearson correlations
showed no significant association between age, gender and
the CSES score, which is similar to the results reported by
Garrod et al. (8) and Bentsen et al. (20). In the present
study, a significant correlation was obtained between the
CSES-DK score and self-rated health. To our knowledge,
no other studies have evaluated the association between
self-rated health and self-efficacy in patients with COPD,
using the CSES. However, associations have been found
between self-rated health and mastery in patients with
COPD, assessed by the chronic respiratory questionnaire
mastery subscale. In that study, subjects who reported poor
health had lower confidence in their ability to manage
their COPD compared with subjects who reported good
health (21), which is in agreement with the results of the
present study.
This study observed a relatively high number of unan-
swered items. Bissonnette et al. (22) also reported on items
that were not applicable, particularly item 11 and item 21.
Furthermore, the Norwegian validation study reports
omission rates up to 19% (20), and the items with high
omission rates are similar to the omitted items in the
Danish validation study. According to Bandura (4), mas-
tery experience is the primary source of self-efficacy.
Therefore, a possible explanation for the high number of
unanswered items is that the respondents could not relate
to situations with which they had no experience, which is
supported by the statements of the respondents during the
validation study.
The main discrepancy between the original version of
CSES and the Danish version is the factor structure. Five
factors were extracted in both versions, but in the Danish
version only one factor concerns emotions, whereas two
factors describing emotions were obtained for the original
scale (‘negative affect’ and ‘intense emotional arousal’).
A supplementary analysis showed that the two emotion
factors correlated 0.92 in the Danish sample, explaining
why only one emotion factor was obtained in our analysis.
In addition to cultural and translation factors, it should be
remembered that the analysis of the original CSES was
based on only 102 patients (5).
Important discrepancies exist with respect to the direc-
tion of the scoring in the currently available literature. In
some studies, a high score indicates high self-efficacy (8,
23), whereas it indicates low self-efficacy in other studies
(7, 22). Furthermore, there is no consensus on how the
CSES score should be presented. Some authors present an
overall scale mean score (3), whereas others present a
score for each factor (23, 24). The use of different scoring
procedures complicates comparison of studies and we hope
this paper can contribute to a more uniform scoring pro-
cedure.
The high correlations between the factor scores shown
in Table 5 suggest that the total CSES-DK score will be
sufficient in most contexts, which is also recommended by
Wigal. The predictive power of the total score and the five
factors can often be compared in research contexts, and
while the intercorrelations among the factors are high,
there is clearly nonoverlapping variance. Consequently,
the factor scores may be useful when detailed information
on self-efficacy in different contexts is needed (5). If factor
scores are essential for the interpretation of the data in a
Danish setting, the factor scores should be derived from the
Danish factor structure.
We have noticed that the paper presenting the source
version of CSES contains two different phrasings of item
10. In the appendix, item 10 is phrased as ‘when I feel
Table 5 Correlations between the factors in the COPD self-efficacy
scale (CSES)-DK
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Factor 1 1 – – – –
Factor 2 0.57* 1 – – –
Factor 3 0.59* 0.69* 1 – –
Factor 4 0.60* 0.22* 0.40* 1 –
Factor 5 0.74* 0.50* 0.60* 0.54* 1
CSES total
score
0.94* 0.79* 0.77* 0.59* 0.80*
COPD, chronic obstructive pulmonary disease.
*Correlation is significant at the 0.01 level (two-tailed).
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distressed about my life’, whereas Table 1 in the paper
presents item 10 as ‘when I experience too much
excitement’ (5). Email correspondence with Wigal has
confirmed that the valid item is ‘when I experience too
much excitement’ and that the authors had not been
aware of this discrepancy, up to this point. Thus, previous
studies applying the CSES may have used the incorrect
version of item 10, which may impede the comparison of
studies.
Methodological limitations
A limitation to the generalisability of the present results is
that the study only included outpatients. However,
because of the measures of reliability and the fluctuating
nature of COPD, it was considered important to validate
the scale on stable COPD patients. A further reason for
choosing the outpatient setting was to facilitate the com-
parison of the psychometric properties of the Danish ver-
sion to the original version, as presented by Wigal et al.
(5).
The evaluation of the psychometric properties of the
CSES-DK could have been strengthened further by eval-
uating the responsiveness of the scale. However, this
would have interfered with the evaluation of repeatability
reliability. The original version of CSES has been evaluated
in terms of responsiveness and displays sensitivity to
change (22).
The validation of the Danish version of CSES primarily
focused on construct validity. The convergent validity
could have been strengthened by comparing the CSES-DK
to other self-efficacy scales. However, self-efficacy is a
dimension-specific construct (4), and to our knowledge, no
validated Danish self-efficacy scale exists for patients with
COPD.
The disease severity was not reported in the original
validation study, which may impede the comparison to the
Danish respondents. Furthermore, the patients in the two
studies were included under different criteria for diagnos-
ing COPD. The respondents in the source version valida-
tion study were included on the basis of reporting chronic
bronchitis, emphysema or both (5), which was previously
used as a definition of COPD (15). However, the current
practice for the diagnosis of COPD follows the NICE
guidelines (14), which have been applied in the present
study.
Implications of the study
The present study has implications for clinical practice as
well as for researchers. Information about COPD patients’
self-efficacy will enable health professionals to organise
interventions designed to increase the patients’ self-effi-
cacy in specific situations (5). Future CSES validation
studies should include COPD patients with exacerbation to
investigate the use of the scale in the acute phase of
COPD. Furthermore, little is known about the respon-
siveness of the CSES-DK, which should be tested in a
Danish setting.
Conclusion
A Danish version of ‘The COPD self-efficacy scale’ (CSES-
DK) has been developed. The Danish version of CSES
showed sufficient reliability, corresponding to the original
version of CSES. Analyses showed an association between
the underlying construct and relevant disease- and socio-
demographic variables, as an indication of construct
validity.
The evaluation of the psychometric properties of the
CSES-DK has identified potential limitations of the scale,
and discrepancies exist between the factor structure of the
original and Danish version. In most contexts, it will be
sufficient to report the CSES total score, but if the nature
of a Danish study requires factor scores, they should be
based on the Danish factor structure. Furthermore, more
studies of the factor structure should be conducted on both
the original CSES and translated versions of the instru-
ment.
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